首页> 外文OA文献 >Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

【2h】

Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

机译：汇总分析阶段3恢复试验：随机，双盲研究，以评估ICLAPRIM与万古霉素治疗急性细菌皮肤和皮肤结构感染的安全性和功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
David B. Huang; G. Ralph Corey; Thomas L. Holland; Thomas Lodise; William ORiordan; Mark H. Wilcox; Thomas M. File; Matthew Dryden; Barbara Balser; Eve Desplats; Antoni Torres;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study) [J] . Holland Thomas L., ORiordan William, McManus Alison, Journal of neurosurgical sciences . 2018,第5期

机译：第3期，随机，双盲，多中心研究，以评估静脉内Iclaprim对急性细菌皮肤和皮肤结构感染的静脉内Iclaprim对急性细菌皮肤和皮肤结构感染的安全性和疗效进行刺激或证实是由于革兰氏阳性病原体（Revive-2研究）
2. A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study) [J] . Holland Thomas L., ORiordan William, McManus Alison, Antimicrobial agents and chemotherapy. . 2018,第5期

机译：第3期，随机，双盲，多中心研究，以评估静脉内Iclaprim对急性细菌皮肤和皮肤结构感染的静脉内Iclaprim对急性细菌皮肤和皮肤结构感染的安全性和疗效进行刺激或证实是由于革兰氏阳性病原体（Revive-2研究）
3. A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies [J] . Huang David B., Noviello Stephanie, Balser Barbara, Clinical therapeutics . 2019,第6期

机译：汇总分析ICLAPRIM与万古霉素治疗静脉注射患者急性细菌皮肤和皮肤结构感染的安全性和疗效分析：第3期复苏研究
4. 1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections [O] . David Huang, G Ralph Corey, Thomas L Holland, -1

机译：1338.在3期REVIVE试验中对伤口感染患者的汇总分析：评估Iclaprim Vs的安全性和有效性的随机双盲研究。万古霉素治疗急性细菌性皮肤和皮肤结构感染
5. A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections [O] . Stephanie Noviello, G. Ralph Corey, Thomas L. Holland, 2020

机译：第3阶段恢复试验中伤口感染患者的汇总分析：随机，双盲研究，评价ICLAPRIM与万古霉素治疗急性细菌皮肤和皮肤结构感染的安全性和功效

Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

著录项

引文网络

相似文献

相关主题

期刊订阅